{"entity":{"type":"insider","cik":"0001457013","url":"/insider/0001457013","json_url":"/insider/0001457013.json","name":"Nguyen Tran","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":17,"first":"2010-09-15","last":"2023-05-17","span_basis":"filed_date"},"name_variants":[{"name":"Nguyen Tran","source":"filing","n_filings":17,"first_seen":"2010-09-15","last_seen":"2023-05-17"}],"transactions":[{"id":8103319,"accession":"0001140361-23-025342","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001140361-23-025342","line_url":"/filing/0001140361-23-025342","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95000.0,"shares_display":"95,000","price_per_share":73.98864723789474,"price_display":"73.99","price_state":"stated","total_value":7028921.4876,"total_display":"7,028,921.49","total_whole":"7,028,921","shares_owned_after":12515.0,"shares_owned_after_display":"12,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-17","scope":"insider","n_lines":5},{"id":8375619,"accession":"0001567619-23-005291","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-23-005291","line_url":"/filing/0001567619-23-005291","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":48.43142126,"price_display":"48.43","price_state":"stated","total_value":484314.2126,"total_display":"484,314.21","total_whole":"484,314","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-17","scope":"insider","n_lines":2},{"id":8450816,"accession":"0001567619-23-003363","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-23-003363","line_url":"/filing/0001567619-23-003363","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":53.33972144,"price_display":"53.34","price_state":"stated","total_value":533397.2144,"total_display":"533,397.21","total_whole":"533,397","shares_owned_after":3864.0,"shares_owned_after_display":"3,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-17","scope":"insider","n_lines":2},{"id":8736204,"accession":"0001567619-23-001097","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-23-001097","line_url":"/filing/0001567619-23-001097","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.53064202,"price_display":"55.53","price_state":"stated","total_value":555306.4202,"total_display":"555,306.42","total_whole":"555,306","shares_owned_after":5923.0,"shares_owned_after_display":"5,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-20","scope":"insider","n_lines":3},{"id":6906523,"accession":"0001567619-22-022010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-22-022010","line_url":"/filing/0001567619-22-022010","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":58.9690226,"price_display":"58.97","price_state":"stated","total_value":589690.226,"total_display":"589,690.23","total_whole":"589,690","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-23","scope":"insider","n_lines":2},{"id":6721057,"accession":"0001140361-22-043172","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-22-043172","line_url":"/filing/0001140361-22-043172","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":61.08535576,"price_display":"61.09","price_state":"stated","total_value":610853.5576,"total_display":"610,853.56","total_whole":"610,854","shares_owned_after":8653.0,"shares_owned_after_display":"8,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-11-25","scope":"insider","n_lines":3},{"id":6332899,"accession":"0001567619-22-018716","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-22-018716","line_url":"/filing/0001567619-22-018716","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":56.43852975,"price_display":"56.44","price_state":"stated","total_value":564385.2975,"total_display":"564,385.30","total_whole":"564,385","shares_owned_after":3371.0,"shares_owned_after_display":"3,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-19","filed_date":"2022-10-21","scope":"insider","n_lines":4},{"id":6964356,"accession":"0001140361-22-034587","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-034587","line_url":"/filing/0001140361-22-034587#line-2","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.7496,"price_display":"30.75","price_state":"stated","total_value":307496.0,"total_display":"307,496.00","total_whole":"307,496","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-23","scope":"insider"},{"id":6376567,"accession":"0001567619-22-016737","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-016737","line_url":"/filing/0001567619-22-016737#line-2","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.1672,"price_display":"30.17","price_state":"stated","total_value":301672.0,"total_display":"301,672.00","total_whole":"301,672","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-26","scope":"insider"},{"id":6281148,"accession":"0001567619-22-014382","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001567619-22-014382","line_url":"/filing/0001567619-22-014382#line-8","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7320.0,"shares_display":"7,320","price_per_share":32.5483,"price_display":"32.55","price_state":"stated","total_value":238253.556,"total_display":"238,253.56","total_whole":"238,254","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-22","scope":"insider"},{"id":6281139,"accession":"0001567619-22-014382","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-22-014382","line_url":"/filing/0001567619-22-014382","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20560.0,"shares_display":"20,560","price_per_share":32.640755228599225,"price_display":"32.64","price_state":"stated","total_value":671093.9275,"total_display":"671,093.93","total_whole":"671,094","shares_owned_after":3205.0,"shares_owned_after_display":"3,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-21","filed_date":"2022-07-22","scope":"insider","n_lines":2},{"id":6281126,"accession":"0001567619-22-014382","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-22-014382","line_url":"/filing/0001567619-22-014382","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Strategy Officer and CFO)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer and CFO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42120.0,"shares_display":"42,120","price_per_share":32.489094795821465,"price_display":"32.49","price_state":"stated","total_value":1368440.6728,"total_display":"1,368,440.67","total_whole":"1,368,441","shares_owned_after":20184.0,"shares_owned_after_display":"20,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-22","scope":"insider","n_lines":2},{"id":4297176,"accession":"0000899243-17-006986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-006986","line_url":"/filing/0000899243-17-006986#line-1","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":51.3172,"price_display":"51.32","price_state":"stated","total_value":51317.2,"total_display":"51,317.20","total_whole":"51,317","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-09","filed_date":"2017-03-09","scope":"insider"},{"id":8797762,"accession":"0000899243-15-009695","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-15-009695","line_url":"/filing/0000899243-15-009695","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":66.16583736,"price_display":"66.17","price_state":"stated","total_value":1984975.1208,"total_display":"1,984,975.12","total_whole":"1,984,975","shares_owned_after":4300.0,"shares_owned_after_display":"4,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-09","filed_date":"2015-12-11","scope":"insider","n_lines":3},{"id":6318341,"accession":"0001209191-14-033103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-033103","line_url":"/filing/0001209191-14-033103#line-1","is_derivative":false,"issuer_cik":"0001457013","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001457013","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2200.0,"shares_display":"2,200","price_per_share":19.6064,"price_display":"19.61","price_state":"stated","total_value":43134.08,"total_display":"43,134.08","total_whole":"43,134","shares_owned_after":2200.0,"shares_owned_after_display":"2,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-09","filed_date":"2014-05-12","scope":"insider"},{"id":4246885,"accession":"0001209191-13-001577","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-001577","line_url":"/filing/0001209191-13-001577#line-2","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":412.0,"shares_display":"412","price_per_share":3.08,"price_display":"3.08","price_state":"stated","total_value":1268.96,"total_display":"1,268.96","total_whole":"1,269","shares_owned_after":49949.0,"shares_owned_after_display":"49,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-02","filed_date":"2013-01-03","scope":"insider"},{"id":2701519,"accession":"0001209191-12-000917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-000917","line_url":"/filing/0001209191-12-000917#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":0.4772,"price_display":"0.48","price_state":"stated","total_value":1574.76,"total_display":"1,574.76","total_whole":"1,575","shares_owned_after":119233.0,"shares_owned_after_display":"119,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-03","filed_date":"2012-01-04","scope":"insider"},{"id":8957821,"accession":"0001209191-11-022936","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-022936","line_url":"/filing/0001209191-11-022936#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":2.8364,"price_display":"2.84","price_state":"stated","total_value":9360.12,"total_display":"9,360.12","total_whole":"9,360","shares_owned_after":104200.0,"shares_owned_after_display":"104,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-12","filed_date":"2011-04-14","scope":"insider"},{"id":7331831,"accession":"0001209191-10-046276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-046276","line_url":"/filing/0001209191-10-046276#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001457013","owner_name":"Nguyen Tran","owner_display_name":"Nguyen Tran","owner_url":"/insider/0001457013","role":"Officer (Vice President and CFO)","role_mark":"O","role_mark_label":"Officer (Vice President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":3.89,"price_display":"3.89","price_state":"stated","total_value":9725.0,"total_display":"9,725.00","total_whole":"9,725","shares_owned_after":27500.0,"shares_owned_after_display":"27,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-15","filed_date":"2010-09-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":34,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001559053","name":"PROTHENA CORP PUBLIC LTD CO","url":"/issuer/0001559053","role":"Officer (Chief Strategy Officer and CFO)","n_filings":13,"first_seen":"2014-05-12","last_seen":"2023-05-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001339455","name":"Somaxon Pharmaceuticals, Inc.","url":"/issuer/0001339455","role":"Officer (SVP and CFO)","n_filings":4,"first_seen":"2010-09-15","last_seen":"2013-01-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001457013","retrieved_at":"2026-08-22T23:14:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}